Emerging Vaccine Technologies
Open Access
Abstract
Vaccination has proven to be an invaluable means of preventing infectious diseases by reducing both incidence of disease and mortality. However, vaccines have not been effectively developed for many diseases including HIV-1, hepatitis C virus (HCV), tuberculosis and malaria, among others. The emergence of new technologies with a growing understanding of host-pathogen interactions and immunity may lead to efficacious vaccines against pathogens, previously thought impossible.Keywords
This publication has 110 references indexed in Scilit:
- Antibody-based protection against HIV infection by vectored immunoprophylaxisNature, 2011
- Design and Characterization of Epitope-Scaffold Immunogens That Present the Motavizumab Epitope from Respiratory Syncytial VirusJournal of Molecular Biology, 2011
- Mapping regions of Epstein–Barr virus (EBV) glycoprotein B (gB) important for fusion function with gH/gLVirology, 2011
- Computational Design of the Sequence and Structure of a Protein-Binding PeptideJournal of the American Chemical Society, 2011
- Crystal structure of the conserved herpesvirus fusion regulator complex gH–gLNature Structural & Molecular Biology, 2010
- Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeysNature Medicine, 2009
- HCMV gH/gL/UL128–131 interferes with virus entry into epithelial cells: Evidence for cell type-specific receptorsProceedings of the National Academy of Sciences, 2008
- High-resolution design of a protein loopProceedings of the National Academy of Sciences, 2007
- Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministeredProceedings of the National Academy of Sciences, 2006
- A universal vaccine for serogroup B meningococcusProceedings of the National Academy of Sciences, 2006